Digest Network Come funziona
Network
/
Società
Th
Non verificato

The Board of Directors of Sinovac Biotech Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniSaluteTitoli e azioni

16 comunicati stampa

Guarda tutti i comunicati
18/11/2025
Biotecnologia
Farmaceutica
Salute
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
24/10/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Announces Appointment of Independent Auditor
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
11/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
09/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
09/07/2025
Biotecnologia
Farmaceutica
Salute
Titoli e azioni
SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
09/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
07/07/2025
Multimedialità
Biotecnologia
Farmaceutica
Salute
Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
07/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
03/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
02/07/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place
Fonte
The Board of Directors of Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0